SEC Form 4 · accession 0001144204-15-071389
Bionik Laboratories Corp. · BNKL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter D. Bloch
Officer — Chairman and CEO · Director
Period of report
Dec 14, 2015
Accepted (ET)
Dec 16, 2015 · 7:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001508381
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.00 | Dec 14, 2015 | A | 1,000,000 | A | — | Dec 14, 2022 | Common Stock, par value $0.001 | 1,000,000 | 1,000,000 | D |
Explanation of responses
- F1The options vest 333,333 on December 14, 2016, 333,333 on December 14, 2017 and 333,334 on December 14, 2018.